8UX6 image
Deposition Date 2023-11-08
Release Date 2024-10-16
Last Version Date 2025-05-28
Entry Detail
PDB ID:
8UX6
Keywords:
Title:
Structure of Fab201 with a T. parva sporozoite neutralizing B cell epitope of p67
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.25
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Fab201 heavy chain
Chain IDs:C (auth: B), D
Chain Length:221
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Fab201 light chain
Chain IDs:A (auth: C), B (auth: A)
Chain Length:216
Number of Molecules:2
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:p67 protein
Gene (Uniprot):p67
Chain IDs:E, F
Chain Length:41
Number of Molecules:2
Biological Source:Theileria parva strain Muguga
Primary Citation
Molecular characterization of a synthetic neutralizing antibody targeting p67 of Theileria parva.
Protein Sci. 34 e70153 e70153 (2025)
PMID: 40384600 DOI: 10.1002/pro.70153

Abstact

The Theileria parva sporozoite surface antigen p67 is a target of the bovine humoral immune response that generates antibodies capable of providing protection against subsequent infection. As a result, p67 has been the subject of efforts aimed at the development of an anti-sporozoite subunit vaccine. Previous studies have identified neutralizing epitopes in the N- and C-terminal regions of the full-length protein and shown that immunization with a C-terminal fragment of p67 (p67C) alone is capable of eliciting protection. To identify additional neutralizing epitopes in p67C, selections were conducted against it using a phage-displayed synthetic antibody library. An antibody that neutralized the sporozoite in vitro was identified, and the crystal structure of a Fab:peptide complex was elucidated. Mutagenesis studies aimed at validating and further characterizing the Fab:peptide interaction identified critical residues involved in binding and neutralization. This study also validates distinct epitopes for previously reported neutralizing antibodies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures